What is the treatment for conjunctivitis (pink eye)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Pink Eye (Conjunctivitis)

Treatment depends on the underlying cause: bacterial conjunctivitis benefits from topical antibiotics (though mild cases are self-limited), viral conjunctivitis requires only supportive care, and allergic conjunctivitis responds to topical antihistamines with mast cell-stabilizing properties. 1

Bacterial Conjunctivitis

Mild Cases

  • Mild bacterial conjunctivitis is self-limited and resolves spontaneously in immune-competent adults without treatment 1
  • However, topical antibacterial therapy provides earlier clinical and microbiological remission during days 2-5 of treatment 1
  • The American Academy of Ophthalmology recommends a 5-7 day course of broad-spectrum topical antibiotics for mild bacterial conjunctivitis 1
  • Topical fluoroquinolones (moxifloxacin, levofloxacin, gatifloxacin, ciprofloxacin, besifloxacin) are effective against common pathogens including Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae 1
  • Alternative options include bacitracin ointment applied 1-3 times daily 2 or erythromycin ointment 3
  • Return for evaluation if no improvement after 3-4 days of treatment 4

Moderate to Severe Cases

  • Characterized by copious purulent discharge, pain, and marked inflammation 1
  • Obtain conjunctival cultures and Gram staining before initiating treatment 1
  • Treatment should be guided by laboratory results 1
  • Consider MRSA in patients from nursing homes or with community-acquired infections; compounded topical vancomycin may be needed for resistant cases 1

Special Bacterial Pathogens

  • Gonococcal conjunctivitis requires systemic antibiotics plus topical therapy with daily monitoring until resolution 1, 4
  • Hospitalization may be necessary for severe cases and is mandatory for neonatal conjunctivitis 4
  • Chlamydial conjunctivitis necessitates systemic antibiotic therapy, as more than 50% of infants have infection at other sites 1, 4
  • Sexual contacts of patients with sexually transmitted conjunctivitis should be treated concurrently 4
  • In low-resource settings with limited antibiotic access, povidone-iodine 1.25% ophthalmic solution can be used for chlamydial conjunctivitis 4

Viral Conjunctivitis

General Management

  • No proven effective treatment exists for eradication of adenovirus infection 1
  • Avoid antibiotics as they provide no benefit and may cause adverse effects 1, 5
  • Patients should minimize contact with others for 10-14 days from symptom onset in the last affected eye 5

Symptomatic Treatment

  • Artificial tears provide comfort and help dilute viral particles 1, 5
  • Cold compresses reduce inflammation and provide relief 1, 5
  • Topical antihistamines alleviate itching and discomfort 1, 5
  • Oral analgesics for pain management 5

Severe Adenoviral Cases

  • Topical corticosteroids may help in severe cases with marked chemosis, lid swelling, epithelial sloughing, or membranous conjunctivitis 1
  • Close monitoring is mandatory when using corticosteroids: measure intraocular pressure periodically and evaluate for glaucoma and cataract 6, 5
  • Prefer corticosteroids with poor ocular penetration (fluorometholone, rimexolone, or loteprednol) to minimize side effects 6, 5
  • Taper slowly to minimum effective dose once inflammation is controlled 6, 5
  • Re-evaluate patients with severe disease within 1 week 6, 5

Herpes Simplex Virus (HSV) Conjunctivitis

  • Topical ganciclovir 0.15% gel three to five times daily OR trifluridine 1% solution five to eight times daily 6, 1
  • Oral antivirals: acyclovir 200-400 mg five times daily, valacyclovir 500 mg two or three times daily, or famciclovir 250 mg twice daily 6, 1
  • Topical corticosteroids potentiate HSV infection and must be avoided 6, 1
  • Topical trifluridine causes epithelial toxicity if used for more than 2 weeks 6, 1
  • Follow-up within 1 week with visual acuity measurement and slit-lamp biomicroscopy 6

Varicella Zoster Virus (VZV) Conjunctivitis

  • Topical antibiotics to prevent secondary bacterial infection as vesicles undergo necrosis 6, 5
  • Oral antivirals for persistent cases: acyclovir 800 mg five times daily for 7 days, valacyclovir 1000 mg every 8 hours for 7 days, or famciclovir 500 mg three times daily for 7 days 5
  • Use caution in patients with impaired renal clearance 5

Allergic Conjunctivitis

First-Line Treatment

  • Topical antihistamines with mast cell-stabilizing properties are the treatment of choice 4
  • Simple measures: wear sunglasses as barriers to airborne allergens, apply cold compresses, use refrigerated artificial tears 4
  • Identify and avoid triggering allergens 4

Persistent or Recurrent Cases

  • Mast cell stabilizers can be used for persistent or recurrent cases 4
  • For severe cases, a brief course (1-2 weeks) of topical corticosteroids with low side-effect profile may be added 4
  • Baseline and periodic intraocular pressure measurement if corticosteroids are used 1

Red Flags Requiring Immediate Ophthalmology Referral

Refer immediately for: 1, 4

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy after 3-4 days
  • Recurrent episodes
  • History of HSV eye disease
  • Immunocompromised state
  • Contact lens wearers (evaluate for corneal ulcers)
  • Neonatal conjunctivitis

Critical Pitfalls to Avoid

  • Never use topical corticosteroids in HSV conjunctivitis without antiviral coverage, as they potentiate infection 1, 4
  • Avoid indiscriminate use of topical antibiotics or corticosteroids, which can induce toxicity and potentially prolong adenoviral infections 4
  • Do not use topical trifluridine for more than 2 weeks due to epithelial toxicity 6, 1
  • Consider sexual abuse in children with gonococcal or chlamydial conjunctivitis 1
  • Delayed referral for gonococcal conjunctivitis can lead to poor outcomes 1

Infection Control Measures

  • Strict handwashing is essential to prevent transmission 5, 7
  • Do not share towels, pillows, or cosmetics 4
  • Contact lens wearers must discontinue use until complete resolution 4
  • Adenovirus can survive for weeks on surfaces; disinfect with sodium hypochlorite 5

References

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Viral Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.